Main page content

Displaying results 1 - 7 of 7
Publication ID: PEP23-02-00-001
Published:

The fourth supplemental resource to SAMHSA’s Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants publication. This document contains information for pregnant people with a substance use disorder and preparing to deliver.

Publication ID: PEP20-06-04-002
Published:

This Advisory is based on TIP 51, Substance Abuse Treatment: Addressing the Specific Needs of Women. It offers guidance to providers and administrators about the particular needs of women during substance use disorder (SUD) treatment.

Publication ID: PEP20-03-02-001
Published:

The EAP Prescription Drug Toolkit and Fact Sheets provide guidance related to counseling, referrals, and follow-up services (e.g., alternatives to prescription drugs, workplace drug misuse and relapse prevention, dangers of combined drug use, screenings, and evaluations before returning to work).

Publication ID: SMA18-5054
Published:

This Clinical Guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The Clinical Guide helps healthcare professionals and patients determine the most clinically appropriate action for a particular situation and informs individualized treatment decisions.

Publication ID: SMA16-4937
Published:

This resource describes the Mental Health Parity and Addiction Equity Act of 2008 for people with employer-sponsored health plans who need treatment for mental and/or substance use disorders. It discusses how to file a claim, the denial of a claim and the appeals process.

Publication ID: SMA15-4426
Published:

This guide assists providers in offering treatment to women living with substance use disorders. It reviews gender-specific research and best practices, such as common patterns of initial use and specific treatment issues and strategies.

Publication ID: SMA13-4789
Published:

This quick guide helps clinicians address the specific needs of women living with substance use disorders. It reviews gender-specific research and best practices—such as common patterns of misuse—and specific screening and treatment strategies.